Cryo-Cell International, Inc.
CCEL
$4.70
-$0.1267-2.63%
AMEX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.10% | 2.33% | 2.05% | 1.94% | 1.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.10% | 2.33% | 2.05% | 1.94% | 1.93% |
| Cost of Revenue | -36.68% | -35.91% | -35.24% | 40.82% | 38.05% |
| Gross Profit | 24.20% | 26.43% | 25.58% | -12.61% | -12.13% |
| SG&A Expenses | 7.69% | 6.20% | 8.38% | 9.93% | 9.17% |
| Depreciation & Amortization | 17.90% | -26.73% | -56.98% | -49.35% | -41.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.70% | -13.14% | -10.78% | 19.10% | 20.02% |
| Operating Income | 1,634.19% | 527.31% | 1,639.04% | -102.98% | -105.58% |
| Income Before Tax | 113.01% | 118.45% | 120.98% | -479.78% | -548.19% |
| Income Tax Expenses | 154.08% | 159.59% | 162.51% | -559.14% | -731.92% |
| Earnings from Continuing Operations | 98.16% | 101.32% | 104.22% | -456.17% | -505.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.16% | 101.32% | 104.22% | -456.17% | -505.57% |
| EBIT | 1,634.19% | 527.31% | 1,639.04% | -102.98% | -105.58% |
| EBITDA | 673.19% | 2,749.94% | 289.85% | -88.83% | -89.49% |
| EPS Basic | 98.09% | 101.31% | 104.14% | -460.18% | -513.21% |
| Normalized Basic EPS | 340.53% | 213.10% | 250.67% | -130.23% | -123.46% |
| EPS Diluted | 97.26% | 100.78% | 104.02% | -463.89% | -515.19% |
| Normalized Diluted EPS | 325.44% | 210.24% | 247.04% | -131.68% | -124.63% |
| Average Basic Shares Outstanding | -2.06% | -2.56% | -2.52% | -2.53% | -2.16% |
| Average Diluted Shares Outstanding | -1.87% | -1.84% | -1.91% | -1.92% | -1.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |